Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Short term Debt (2021 - 2023)

Silo Pharma's Short term Debt history spans 3 years, with the latest figure at $660279.0 for Q1 2023.

  • For Q1 2023, Short term Debt rose 918.34% year-over-year to $660279.0; the TTM value through Mar 2023 reached $660279.0, up 918.34%, while the annual FY2022 figure was $364216.0, 12.85% down from the prior year.
  • Short term Debt for Q1 2023 was $660279.0 at Silo Pharma, up from $364216.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $660279.0 in Q1 2023 and bottomed at $2366.0 in Q1 2021.
  • The 3-year median for Short term Debt is $72102.0 (2021), against an average of $190123.1.
  • The largest YoY upside for Short term Debt was 2640.45% in 2022 against a maximum downside of 77.19% in 2022.
  • A 3-year view of Short term Debt shows it stood at $417937.0 in 2021, then decreased by 12.85% to $364216.0 in 2022, then surged by 81.29% to $660279.0 in 2023.
  • Per Business Quant, the three most recent readings for SILO's Short term Debt are $660279.0 (Q1 2023), $364216.0 (Q4 2022), and $16447.0 (Q3 2022).